Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas

被引:24
|
作者
Kurotani, R
Yasuda, M
Oyama, K
Egashira, N
Sugaya, M
Teramoto, A
Osamura, RY [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan
[2] Nippon Med Coll, Dept Neurosurg, Tokyo 113, Japan
关键词
gp80; gp130; human pituitary adenoma; human pituitary gland; IL-6; immunohistochemistry;
D O I
10.1038/modpathol.3880392
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Interleukin-6 (IL-6) is an important cytokine in cen proliferation and differentiation in several organs. It has also been reported that IL-6 plays a role in secretion or release of pituitary hormones in pituitary hormone-secreting cells and pituitary adenomas, but convincing data in situ have not yet been reported. In this study, we examined the participation of IL-6 in the production of pituitary hormones and the differences between human normal pituitary glands and pituitary adenomas by determination of the localization or expression of IL-6, IL-6 receptor (IL-6R, gp80), and the signal-transducing subunit (gp130) of the receptor using immunohistochemical staining and RT-PCR. IL-6 was mainly expressed in ACTH- and FSH/LH-secreting cells in normal pituitary glands, as shown by double staining. gp 80 and gp130 were coexpressed in almost all GH- and PRL-secreting cells and in approximately 30% of FSH/LH-secreting cells. RT-PCR showed that IL-6 mRNA was expressed in only one of all the pituitary adenomas examined, whereas gp 80 and gp 130 mRNAs were detected in all these pituitary adenomas. In conclusion, IL-6 was mainly expressed in ACTH- and FSH/LH-secreting cells, and the receptors were expressed in GH-, PRL- and FSH/LH-secreting cells in human normal pituitary glands. Furthermore, our data emphasized that the mechanism of IL-6 function in human pituitary adenoma cells is distinct from that in normal pituitary cells.
引用
收藏
页码:791 / 797
页数:7
相关论文
共 50 条
  • [21] Intrapituitary Expression and Regulation of the gp130 Cytokine Interleukin-6 and Its Implication in Pituitary Physiology and Pathophysiology
    Renner, Ulrich
    De Santana, Eliane Correa
    Gerez, Juan
    Froehlich, Bianca
    Haedo, Mariana
    Pereda, Marcelo Paez
    Onofri, Chiara
    Stalla, Guenter K.
    Arzt, Eduardo
    NEUROIMMUNOMODULATION: FROM FUNDAMENTAL BIOLOGY TO THERAPY, 2009, 1153 : 89 - 97
  • [22] In vivo activation of the interleukin-6 receptor/gp130 signaling pathway in pituitary corticotropes of lipopolysaccharide-treated rats
    Gautron, L
    Lafon, P
    Tramu, G
    Layé, S
    NEUROENDOCRINOLOGY, 2003, 77 (01) : 32 - 43
  • [23] DIFFERENTIAL REGULATION OF INTERLEUKIN-6 RECEPTOR AND GP130 GENE-EXPRESSION IN RAT HEPATOCYTES
    NESBITT, JE
    FULLER, GM
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (01) : 103 - 112
  • [24] Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor
    Adam, Nina
    Rabe, Bjoern
    Suthaus, Jan
    Groetzinger, Joachim
    Rose-John, Stefan
    Scheller, Juergen
    JOURNAL OF VIROLOGY, 2009, 83 (10) : 5117 - 5126
  • [25] A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease
    Mitsuyama, K
    Tomiyasu, N
    Suzuki, A
    Takaki, K
    Takedatsu, H
    Masuda, J
    Yamasaki, H
    Matsumoto, S
    Tsuruta, O
    Toyonaga, A
    Sata, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (01): : 125 - 131
  • [26] Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6
    Chen, Daming
    Nicholas, John
    JOURNAL OF VIROLOGY, 2006, 80 (19) : 9811 - 9821
  • [27] Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex
    Boulanger, MJ
    Chow, DC
    Brevnova, EE
    Garcia, KC
    SCIENCE, 2003, 300 (5628) : 2101 - 2104
  • [28] INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR GENE-EXPRESSION IN PITUITARY-TUMORS
    REZAI, AR
    REZAI, A
    MARTINEZMAZA, O
    VANDERMEYDEN, M
    WEISS, MH
    JOURNAL OF NEURO-ONCOLOGY, 1994, 19 (02) : 131 - 135
  • [29] CRITICAL CYTOPLASMIC REGION OF THE INTERLEUKIN-6 SIGNAL TRANSDUCER GP130 IS CONSERVED IN THE CYTOKINE RECEPTOR FAMILY
    MURAKAMI, M
    NARAZAKI, M
    HIBI, M
    YAWATA, H
    YASUKAWA, K
    HAMAGUCHI, M
    TAGA, T
    KISHIMOTO, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11349 - 11353
  • [30] COMBINING 2 MUTATIONS OF HUMAN INTERLEUKIN-6 THAT AFFECT GP130 ACTIVATION RESULTS IN A POTENT INTERLEUKIN-6 RECEPTOR ANTAGONIST ON HUMAN MYELOMA CELLS
    EHLERS, M
    DEHON, FD
    BOS, HK
    HORSTEN, U
    KURAPKAT, G
    VANDELEUR, HS
    GROTZINGER, J
    WOLLMER, A
    BRAKENHOFF, JPJ
    ROSEJOHN, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) : 8158 - 8163